AM-Pharma raises EUR 12.2M

AM-Pharma B.V. (Bunnik, The Netherlands) raised EUR 12.2 million ($15.8 million) in a tranched series E round led by Gilde Healthcare.

Existing investors participating in the new round included the venture arm of AbbVie (NYSE:ABBV); BB Biotech Ventures; Idinvest Partners; Inventages Venture Capital; Kurma Biofund; and Ysios Capital Partners. The round includes two tranches, but AM-Pharma declined to disclose details of its structure. ...